Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score 18.87
- Piotroski Score 5.00
- Grade Buy
- Symbol (PRCT)
- Company PROCEPT BioRobotics Corporation
- Price $80.08
- Changes Percentage (0.69%)
- Change $0.55
- Day Low $79.31
- Day High $82.07
- Year High $85.81
PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. As of December 31, 2021, it had an install base of 130 AquaBeam Robotic Systems worldwide comprising 78 in the United States. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in Redwood City, California.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 10/29/2024
- Fiscal Year End N/A
- Average Stock Price Target $75.00
- High Stock Price Target $95.00
- Low Stock Price Target $49.00
- Potential Upside/Downside N/A
- Consensus Rating Strong Sell
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$2.12
- Trailing P/E Ratio -31.87
- Forward P/E Ratio -31.87
- P/E Growth -31.87
- Net Income $-105,897,000
Income Statement
Quarterly
Annual
Latest News of PRCT
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Procept Biorobotics Corporation (PRCT): Why Are Short Sellers Betting Against This Hospital Tech Innovator?
PROCEPT BioRobotics Corp. (NASDAQ: PRCT) was analyzed against other worst small cap AI stocks. The recent interest rate cut by the Fed aimed at stabilizing the labor market....
By Yahoo! Finance | 1 week ago -
PROCEPT BioRobotics Corporation (NASDAQ:PRCT) Second-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year
PROCEPT BioRobotics (NASDAQ:PRCT) recently exceeded revenue expectations, with a loss smaller than anticipated. Analysts predict a 23% revenue increase in 2024, with a slight improvement in loss per s...
By Yahoo! Finance | 1 month ago
